Mitsubishi UFJ Asset Management Co. Ltd. Raises Position in Agilent Technologies, Inc. $A

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Agilent Technologies, Inc. (NYSE:A) by 6.5% in the second quarter, Holdings Channel.com reports. The firm owned 695,310 shares of the medical research company’s stock after acquiring an additional 42,642 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Agilent Technologies were worth $92,358,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC boosted its stake in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after acquiring an additional 769 shares during the period. Geneos Wealth Management Inc. raised its position in Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after acquiring an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its position in Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after acquiring an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Agilent Technologies in the second quarter valued at $273,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Piper Sandler started coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a research note on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective for the company. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. TD Cowen upped their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Barclays increased their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Stock Up 0.1%

Agilent Technologies stock opened at $148.66 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm has a market capitalization of $41.98 billion, a price-to-earnings ratio of 29.85, a price-to-earnings-growth ratio of 2.63 and a beta of 1.25. The stock’s fifty day moving average is $135.97 and its two-hundred day moving average is $125.68. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The business’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 6.03 EPS for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.